A PHASE 2 OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE COMBINATION OF NIRAPARIB AND TSR-042 IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER (MOONSTONE)
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Gynecologic Oncology Group
Start Date
November 18, 2019
End Date
January 4, 2023
Administered By
Duke Cancer Institute
Awarded By
Gynecologic Oncology Group
Start Date
November 18, 2019
End Date
January 4, 2023